SAN DIEGO, Nov. 29, 2016 /PRNewswire/ -- GenomeDx Biosciences today announced that ten presentations featuring Decipher® Prostate and Bladder data will be presented at the 17th Annual Meeting of the ...
GenomeDx Biosciences today announced that the robust Decipher® genomic analysis platform, successfully classified various subtypes of bladder cancer based on the genomic expression of certain ...
GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant ...
Argo Biopharmaceutical Co. Ltd. and its RNAi work drew Novartis AG back to the table for a third time, as the companies entered a potential $5.2 billion deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results